BrainsWay Ltd.
BrainsWay Ltd. (BWAY) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
bway · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for BrainsWay Ltd. (BWAY) measures how much investors pay for each dollar of the company's trailing earnings. BWAY's current PE ratio of 61.81x is calculated by dividing its stock price of $14.41 by its TTM earnings per share of $0.23. +57.1% elevated vs 5Y avg 39.3x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2012 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
BrainsWay Ltd.You BWAY | $565M | 61.81x | — | $0.23 |
 Cerus Corporation CERS | $521M | N/A | — | -$0.08 |
 CVRx, Inc. CVRX | $143M | N/A | — | -$2.04 |
 Delcath Systems, Inc. DCTH | $378M | 134.00x | — | $0.08 |
 908 Devices Inc. MASS | $306M | N/A | — | -$1.01 |
 NeuroPace, Inc. NPCE | $533M | N/A | — | -$0.66 |
 RxSight, Inc. RXST | $205M | N/A | — | -$0.95 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 23.77x | $0.40 | -56.7% | |
2024-12-31 FY2024 | 54.89x | $0.09 | — | |
2023-12-31 FY2023 | — | $-0.13 | — | |
2022-12-31 FY2022 | — | $-0.40 | — | |
2021-12-31 FY2021 | — | $-0.21 | — | |
2020-12-31 FY2020 | — | $-0.24 | — | |
2019-12-31 FY2019 | — | $-0.50 | — | |
2018-12-31 FY2018 | — | $-0.39 | — | |
2017-12-31 FY2017 | — | $-0.48 | — | |
2016-12-31 FY2016 | — | $-0.17 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for BrainsWay Ltd. (BWAY) measures how much investors pay for each dollar of the company's trailing earnings. BWAY's current PE ratio of 61.81x is calculated by dividing its stock price of $14.41 by its TTM earnings per share of $0.23.
Frequently asked questions
BWAY pe ratio · 6 questionsBWAY's current PE ratio is 61.81x as of 2026-06-08, based on a stock price of $14.41 and TTM EPS of $0.23. Data sourced from Financial Modeling Prep via BWAY's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · BrainsWay Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08